A total of 83.1% of investigators and 84.2% of patients reported clinical efficacy, which was excellent in almost one-third of patients
Join us for our upcoming webinar, Optimizing GLP-1 outcomes with the right digestive health strategy , where clinical and industry experts will share the latest data, real-world insights, and practical steps for integrating GI care into your GLP-1 approach.
The reason people keep comparing it with retatrutide is that retatrutide may offer even more upside
Hong Y, Downey T, Eu KW, Koh PK, Cheah PY
The most common side effects include: Nausea Constipation or diarrhea Mild fatigue These are often temporary and tend to improve as your body adjusts
Cannot redeclare control with same name "grid_4_cta_background_attachment_alert"